Home / Rivaroxaban / United States
US ATC B01AF01 · updated 2 Nov 2026
Rivaroxaban shortage in United States
Is there a Rivaroxaban shortage in United States?
Yes. As of 2 Nov 2026, 1 Rivaroxaban product is reported short in United States, the first since 18 Sep 2026. No return date has been given. Main reason: not stated.
Also short in Canada, Germany, France, Italy, Spain, Ireland, Austria, Belgium, Switzerland, Czechia, Sweden, Japan. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Xarelto, For Suspension, 155 mg (NDC 50458-575-01) discontinuation | Janssen Pharmaceuticals | 18 Sep 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).